Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis
- 31 December 2012
- journal article
- research article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 84 (3) , 340-349
- https://doi.org/10.1016/j.critrevonc.2012.03.007
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trialAnti-Cancer Drugs, 2010
- American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderlyLung Cancer, 2008
- Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancerCancer, 2007
- Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study GroupJournal of Clinical Oncology, 2005
- Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)Journal of Clinical Oncology, 2005
- Chemotherapy Use, Outcomes, and Costs for Older Persons With Advanced Non–Small-Cell Lung Cancer: Evidence From Surveillance, Epidemiology and End Results–MedicareJournal of Clinical Oncology, 2004
- Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge BaseJournal of Clinical Oncology, 2001
- Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999